Suppr超能文献

粪便免疫化学检测阳性后结肠镜检查不依从会使结直肠癌死亡风险增加一倍。

Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.

机构信息

Veneto Tumour Registry, Azienda Zero, Padova, Italy

Veneto Tumour Registry, Azienda Zero, Padova, Italy.

出版信息

Gut. 2022 Mar;71(3):561-567. doi: 10.1136/gutjnl-2020-322192. Epub 2021 Mar 31.

Abstract

BACKGROUND

The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy after a positive FIT is associated with increased CRC incidence and mortality.

METHODS

The FIT-based CRC screening programme in the Veneto region (Italy) invited persons aged 50 to 69 years with a positive FIT (>20 µg Hb/g faeces) for diagnostic colonoscopy at an endoscopic referral centre. In this retrospective cohort study, we compared the 10-year cumulative CRC incidence and mortality among FIT positives who completed a diagnostic colonoscopy within the programme (compliers) and those who did not (non-compliers), using the Kaplan-Meier estimator and Cox-Aalen models.

RESULTS

Some 88 013 patients who were FIT positive complied with colonoscopy (males: 56.1%; aged 50-59 years: 49.1%) while 23 410 did not (males: 54.6%; aged 50-59 years: 44.9%).The 10-year cumulative incidence of CRC was 44.7 per 1000 (95% CI, 43.1 to 46.3) among colonoscopy compliers and 54.3 per 1000 (95% CI, 49.9 to 58.7) in non-compliers, while the cumulative mortality for CRC was 6.8 per 1000 (95% CI, 5.9 to 7.6) and 16.0 per 1000 (95% CI, 13.1 to 18.9), respectively. The risk of dying of CRC among non-compliers was 103% higher than among compliers (adjusted HR, 2.03; 95% CI, 1.68 to 2.44).

CONCLUSION

The excess risk of CRC death among those not completing colonoscopy after a positive faecal occult blood test should prompt screening programmes to adopt effective interventions to increase compliance in this high-risk population.

摘要

背景

粪便免疫化学检测(FIT)阳性但未行结肠镜检查的患者罹患结直肠癌(CRC)的风险尚不清楚。我们评估了 FIT 阳性后不进行结肠镜检查是否与 CRC 发病率和死亡率增加相关。

方法

意大利威尼托地区基于 FIT 的 CRC 筛查项目邀请了年龄在 50 至 69 岁之间、FIT 阳性(粪便血红蛋白>20μg/g)的人群到内镜转诊中心进行诊断性结肠镜检查。在这项回顾性队列研究中,我们使用 Kaplan-Meier 估计值和 Cox-Aalen 模型比较了在项目内完成诊断性结肠镜检查的 FIT 阳性者(依从者)和未完成者(不依从者)的 10 年 CRC 累计发病率和死亡率。

结果

88013 名 FIT 阳性者接受了结肠镜检查(男性占 56.1%;年龄 50-59 岁者占 49.1%),23410 名 FIT 阳性者未接受结肠镜检查(男性占 54.6%;年龄 50-59 岁者占 44.9%)。结肠镜检查依从者的 10 年 CRC 累计发病率为 44.7/1000(95%CI,43.1 至 46.3),不依从者为 54.3/1000(95%CI,49.9 至 58.7),CRC 累计死亡率分别为 6.8/1000(95%CI,5.9 至 7.6)和 16.0/1000(95%CI,13.1 至 18.9)。不依从者 CRC 死亡风险比依从者高 103%(校正 HR,2.03;95%CI,1.68 至 2.44)。

结论

粪便潜血试验阳性后不进行结肠镜检查的患者 CRC 死亡风险增加,这应促使筛查项目采取有效干预措施,提高高危人群的依从性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验